Peroxisomal proteins

Peroxisomal proteins represent a broad class of enzymes, transporters, and biogenesis factors localized to the peroxisome, an organelle vital for various metabolic pathways. These proteins facilitate the alpha- and beta-oxidation of fatty acids, particularly very long-chain fatty acids (VLCFAs), and are essential for the biosynthesis of ether phospholipids and bile acids (Source: NCBI). A critical subset, the peroxin (PEX) proteins, governs the assembly of the peroxisomal membrane and the import of matrix enzymes. Defects in these proteins result in Peroxisome Biogenesis Disorders (PBDs), such as Zellweger syndrome, which are characterized by severe neurological and systemic impairment (Source: PubMed, PMID: 26612207). While the term peroxisomal proteins refers to a collective group rather than a single drug target, specific members like ABCD1 and various acyl-CoA oxidases are focal points for treating metabolic conditions. Pharmacological intervention often involves the use of PPAR-alpha agonists, such as fibrates, which upregulate the expression of peroxisomal enzymes to lower lipid levels (Source: StatPearls). Additionally, therapeutic strategies for peroxisomal disorders include substrate reduction therapies and emerging gene therapies aimed at restoring functional protein levels (Source: NIH). Monitoring these proteins and their metabolic outputs is crucial for diagnosing and managing inherited metabolic diseases. The complexity of the peroxisomal proteome presents both a challenge and an opportunity for precision medicine in metabolic health.

Other names

Peroxisomal matrix proteinsPeroxisomal membrane proteinsPeroxinsPEX proteinsPMPs

Activation of peroxisome proliferator-activated receptors (PPARs) to induce peroxisomal gene expression; restoration of peroxisomal protein import or enzymatic activity via gene therapy or substrate reduction.